Cravatex Q2 FY27 consolidated revenue at Rs 5,346.18 lakh, PAT Rs 462.16 lakh
For the quarter ended 30.09.2026, Cravatex’s consolidated revenue from operations was Rs 5,346.18 lakh and profit after tax was Rs 462.16 lakh versus Rs 5,144.52 lakh and Rs 521.60 lakh a year
Key takeaways
- Revenue from operations was Rs 5,346.18 lakh vs Rs 5,144.52 lakh a year earlier.
- Total income stood at Rs 5,683.15 lakh vs Rs 5,524.03 lakh in Q2 last year.
- Profit before tax was Rs 597.15 lakh vs Rs 607.92 lakh in the year-ago quarter.
- Profit for the period was Rs 462.16 lakh vs Rs 521.60 lakh a year earlier.
- Basic and diluted EPS were Rs 17.88 vs Rs 20.18 in the corresponding quarter.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 5,346.18 lakh | Rs 5,144.52 lakh | +3.9% |
| PAT | Rs 462.16 lakh | Rs 521.60 lakh | -11.4% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 8.64% of revenue, down 149 bps from 10.14%.
- Purchases of stock-in-trade took 50.8% of revenue, against 60.4% a year earlier.
• Revenue from Operations (quarter ended 30.09.2026): Rs 5,346.18 lakh vs Rs 5,144.52 lakh (quarter ended 30.09.2025)
• Other Income: Rs 336.97 lakh vs Rs 379.51 lakh
• Total Income (I+II): Rs 5,683.15 lakh vs Rs 5,524.03 lakh
• Purchase of Stock-in-Trade: Rs 2,715.31 lakh vs Rs 3,106.69 lakh
• Change in Inventories of Stock-in-Trade: Rs 103.97 lakh vs Rs (424.93) lakh
• Employee Benefits Expense: Rs 733.20 lakh vs Rs 714.50 lakh
• Finance Costs: Rs 7.82 lakh vs Rs 9.02 lakh
• Depreciation and Amortisation Expense: Rs 37.58 lakh vs Rs 38.15 lakh
• Other Expenses: Rs 1,488.12 lakh vs Rs 1,472.68 lakh
• Total Expenses (IV): Rs 5,086.00 lakh vs Rs 4,916.11 lakh
• Profit/(Loss) before Exceptional Items and Tax (V): Rs 597.15 lakh vs Rs 607.92 lakh
• Profit/(Loss) before Tax (VII): Rs 597.15 lakh vs Rs 607.92 lakh
• Current Tax: Rs (135.50) lakh vs Rs (86.96) lakh
• Deferred Tax: Rs 0.54 lakh vs Rs (0.57) lakh
• Short/(Excess) provision of the earlier period: Rs (0.03) lakh vs Rs 1.21 lakh
• Total Tax Expenses: Rs (134.99) lakh vs Rs (86.32) lakh
• Profit/(Loss) for the period (IX): Rs 462.16 lakh vs Rs 521.60 lakh
• Total Comprehensive Income for the year (XI): Rs 462.16 lakh vs Rs 521.60 lakh
• Earnings Per Equity Share – Basic: Rs 17.88 vs Rs 20.18
• Earnings Per Equity Share – Diluted: Rs 17.88 vs Rs 20.18
According to the statement of unaudited consolidated financial results for the quarter ended 30.09.2026, revenue from operations increased to Rs 5,346.18 lakh from Rs 5,144.52 lakh in the corresponding quarter of the previous year, while other income declined to Rs 336.97 lakh from Rs 379.51 lakh. This took total income to Rs 5,683.15 lakh compared with Rs 5,524.03 lakh a year earlier.
On the cost side, purchase of stock-in-trade was lower at Rs 2,715.31 lakh versus Rs 3,106.69 lakh, while the change in inventories of stock-in-trade moved to Rs 103.97 lakh from Rs (424.93) lakh. Employee benefits expense rose to Rs 733.20 lakh from Rs 714.50 lakh, and other expenses were Rs 1,488.12 lakh against Rs 1,472.68 lakh. Total expenses increased to Rs 5,086.00 lakh from Rs 4,916.11 lakh. Profit before tax for the quarter was Rs 597.15 lakh compared with Rs 607.92 lakh in the same quarter last year. After total tax expenses of Rs (134.99) lakh versus Rs (86.32) lakh, profit for the period stood at Rs 462.16 lakh against Rs 521.60 lakh. Basic and diluted earnings per equity share were Rs 17.88, down from Rs 20.18 in the corresponding prior quarter, as per the statement of financial results.
Track Cravatex Ltd
Cruxal reads every Cravatex Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
